Actionable news
All posts from Actionable news

Early movers: PFE, BIIB, TAP, CVS, MNK, IMS, CLX, COST & more

Check out which companies are making headlines before the bell:

Pfizer — The drug giant and Dow component beat estimates by 12 cents a share with adjusted quarterly profit of 67 cents per share. Revenue was above forecasts, and the company also raised its full-year earnings forecast as it integrates its Hospira acquisition, as well as boosting sales of new cancer treatments.

Biogen — Biogen is spinning off its hemophilia business as a separate, publicly traded company. The company will be named at a later date.

Molson Coors — The beer brewer earned an adjusted 54 cents per share for its most recent quarter, 11 cents a share above estimates. Revenue also beat analysts' forecasts. The company's bottom line was helped improved demand and lower costs.

CVS Health — The drug store operator beat estimates by 2 cents a share with adjusted quarterly profit of $1.18 per share. Revenue beat Street consensus, as well. Increased demand for the company's pharmacy benefit management services was a key driver of its results for the quarter.

Mallinckrodt — The drugmaker reported adjusted quarterly profit of $2.01 per share, well above estimates of $1.73 a share. Revenue also beat estimates. Mallinckrodt gave a full-year forecast above analysts' estimates, with the company saying its strategy of acquiring...